Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seng-Lai Tan

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Recent Patents on Anti-Infective Drug Discovery|August 5, 2008
NS5A--from obscurity to new target for HCV therapyUli Schmitz, Seng-Lai Tan
Future Medicinal Chemistry|November 20, 2014
Small-molecule inhibitors of spleen tyrosine kinase as therapeutic agents for immune disorders: will promise meet expectations?Matthew C Lucas, Seng-Lai Tan
The Biochemical Journal|October 23, 2003
Emerging and diverse roles of protein kinase C in immune cell signallingSeng-Lai Tan, Peter J Parker
Current Medicinal Chemistry|September 27, 2005
Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infectionShu-Hui Chen, Seng-Lai Tan
Drug Discovery Today|March 3, 2007
Emerging host cell targets for hepatitis C therapyYupeng He, Wei Duan, Seng-Lai Tan
International Reviews of Immunology|July 27, 2013
B-cell antigen receptor signaling in chronic lymphocytic leukemia: therapeutic targets and translational opportunitiesRonald J Hill, Yan Lou, Seng-Lai Tan
Expert Opinion on Therapeutic Targets|April 16, 2008
Protein kinase C isozymes as potential therapeutic targets in immune disordersMatthew R Lee, Wei Duan, Seng-Lai Tan
Current Opinion in Pharmacology|September 8, 2004
Strategies for hepatitis C therapeutic intervention: now and nextSeng-Lai Tan, Yupeng He, Ying Huang, et al.
Nature Reviews. Drug Discovery|November 5, 2002
Hepatitis C therapeutics: current status and emerging strategiesSeng-Lai Tan, Arnim Pause, Yuguang Shi, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 24, 2007
Cytokine-activated natural killer cells exert direct killing of hepatoma cells harboring hepatitis C virus repliconsJonathan Larkin, Anne Bost, John I Glass, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Recent Patents on Anti-Infective Drug Discovery|August 5, 2008
NS5A--from obscurity to new target for HCV therapyUli Schmitz, Seng-Lai Tan
Future Medicinal Chemistry|November 20, 2014
Small-molecule inhibitors of spleen tyrosine kinase as therapeutic agents for immune disorders: will promise meet expectations?Matthew C Lucas, Seng-Lai Tan
The Biochemical Journal|October 23, 2003
Emerging and diverse roles of protein kinase C in immune cell signallingSeng-Lai Tan, Peter J Parker
Current Medicinal Chemistry|September 27, 2005
Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infectionShu-Hui Chen, Seng-Lai Tan
Drug Discovery Today|March 3, 2007
Emerging host cell targets for hepatitis C therapyYupeng He, Wei Duan, Seng-Lai Tan
International Reviews of Immunology|July 27, 2013
B-cell antigen receptor signaling in chronic lymphocytic leukemia: therapeutic targets and translational opportunitiesRonald J Hill, Yan Lou, Seng-Lai Tan
Expert Opinion on Therapeutic Targets|April 16, 2008
Protein kinase C isozymes as potential therapeutic targets in immune disordersMatthew R Lee, Wei Duan, Seng-Lai Tan
Current Opinion in Pharmacology|September 8, 2004
Strategies for hepatitis C therapeutic intervention: now and nextSeng-Lai Tan, Yupeng He, Ying Huang, et al.
Nature Reviews. Drug Discovery|November 5, 2002
Hepatitis C therapeutics: current status and emerging strategiesSeng-Lai Tan, Arnim Pause, Yuguang Shi, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 24, 2007
Cytokine-activated natural killer cells exert direct killing of hepatoma cells harboring hepatitis C virus repliconsJonathan Larkin, Anne Bost, John I Glass, et al.
Pageof 4